JC: Epistaxis – The NoPAC trial – Does TXA work?
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other
JC: Early plasma use in traumatic brain injury. St Emlyn’s Read More
This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma,
JC: Should we rubber STAAMP prehospital TXA? Read More
Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed
JC: Blood Products in Trauma – What’s the Best (I)TACTIC? Read More
Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also
JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s Read More
Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence
JC: TXA in severe head injury. St Emlyn’s Read More
The top ten trauma papers of 2019-20
Top trauma papers of 2019-2020. St Emlyn’s Read More
No one likes getting a pulmonary embolism. Or a deep vein thrombosis. And because about 60% of all blood clots are associated with hospitalisation for acute illness​1​, we take the
Clot’s the Problem? Vena Cava filters in trauma patients. St Emlyn’s Read More